Braeburn plans $20m NC plant; awaits FDA decision on subdermal buprenorphine
Braeburn Pharmaceuticals will establish an R&D and manufacturing site in North Carolina for its subdermal implant candidate to treat opioid addiction.
Archives for March 22, 2016
Meringue? No, you're not wrong: TxCell outlines unusual Ovasave delivery method
TxCell is working on new ways of delivering its Crohn's disease therapy Ovasave that will replace the somewhat unusual method it is using in clinical trials.
Lonza: More pharmas among top customers in 2015; Strong franc could erode Swiss industry
Drug companies were a more important source of revenue for Lonza in 2015 than in previous years with four of its five biggest spending customers coming from the pharmaceutical sector.
Evotec forms spin-off company to treat immunological disorders
Evotec AG has formed a spin-off company that will focus on nanoparticle-based therapeutics to treat immunological disorders.
Propanc receives $1.2m to fast track preclinical studies
Propanc Health Group Corporation has received $1.2m from an institutional investor in order to fast track preclinical activities for its lead product, PRP.